Characteristics of pain following intracavernous injection of prostaglandin E1

Journal of Korean Medical Science

Volumn 12, Issue 4, 1997, Pages 327-331

  Kim, Sae Chul ^a   Lee, Sung Woon ^a   Seo, Kyung Keun ^a  

^a Chung Ang University   (South Korea)

Author keywords

Erectile dysfunction; Intracavernous injection; Pain; Prostaglandin E1

Indexed keywords

PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; INCIDENCE; INJECTION; MALE; METHODOLOGY; MIDDLE AGED; ORGANIC IMPOTENCE; PAIN; PAIN ASSESSMENT; PENIS; PROSPECTIVE STUDY;

ADULT; AGED; ALPROSTADIL; ANALYSIS OF VARIANCE; DIABETES COMPLICATIONS; HUMANS; IMPOTENCE, VASCULOGENIC; INCIDENCE; INJECTIONS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PENIS; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 0031204691     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1997.12.4.327     Document Type: Article

References (23)

1. Fallon B. Intracavernous injection therapy for male erectile dysfunction. Urol Clin N Amer 1995 ; 22 : 833-45.
2. Montague DK, Barada JH, Belker AM, Levine LA, Nadig PW, Roehrborn CG, Sharlip ID, Bennett AH. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J Urol 1996 ; 156 : 2007-11.
3. Mahmoud KZ, El Dakhli MR, Fahmi IM, Abdel-Aziz AA. Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients. J Urol 1992 ; 147 : 623-6.
4. Chen J, Godschalk MF, Katz PG, Mulligan T. Incidence of penile pain after injection of a new formulation of prostaglandin E1. J Urol 1995 ; 154 : 77-9.
5. 1 versus phentolamine/papaverine for the treatment of erectile impotence : a double-blind comparison. J Urol 1989 ; 141 : 549-50.
6. 1 decreases associated penile pain. Urology 1996 ; 47 : 903-4.
7. von Heyden B, Donatucci CF, Marshall GA, Brock GB, Lue TF. A prostaglandin E1 dose-response study in man. J Urol 1993 ; 150 : 1825-8.
8. Earle CM, Chew KK, Stucky BGA, Keogh EJ. Pain with intracavernosal therapy. Int J Impotence Res 1996 ; 8 : 114.
9. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity : a comparison of six methods. Pain 1986 ; 27 : 117-26.
10. Ferraz MB, Quaresma MR, Aquino LRL, Atra E, Tugwell P, Goldsmith CH. Realibility of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 1990 ; 17 : 1022-4.
11. Grossman SA, Sheidler VR, McGuire DB, Geer C, Santor D, Piantadosi S. A comparison of the Hopkins pain rating instrument with standard visual analogue and verbal descriptor scales in patients with cancer pain. J Pain Symptom Manage 1992 ; 7 : 196-203.
12. 1 with combination of prostaglandin E1 and lidocaine in the treatment of organic impotence. Urology 1995 ; 45 : 1032-6.
13. 1: a double-blind, placebo-controlled, dose-response study. J Urol 1994 ; 151 : 1530-2.
14. Vanderschueren D, Heyrman RM, Keogh EJ, Casey RW, Weiske WH, Ogrinc FG, de Koning Gans HJ. A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. J Urol 1995 ; 154 : 1744-7.
15. Melzack R. The short-form McGill pain questionnaire. Pain 1987 ; 30 : 191-7.
16. 1. J Urol 1991 ; 146 : 786-9.
17. Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantadosi, S. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage 1991 ; 6 : 53-7.
18. 1 in the treatment of erectile dysfunction. J Urol 1988 ; 140 : 525-7.
19. 1. J Urol 1996 ; 156 : 999-1000.
20. Valley MA. Pain measurement. In : Raj PP, ed. Pain Medicine : a comprehensive review. St. Louis : Mosby, 1996 ; 36-45.
21. 1 for impotency. Urology 1994 ; 43 : 84-7.
22. Schramek P, Plas EG, Hübner WA, Pflüger H. Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction. J Urol 1994 ; 152 : 1108-10.
23. Linet OL, Orgrinc FG. Intracavernosal alprostadil therapy in the diabetic patients with erectile dysfunction. Presented at a symposium - erectile dysfunction : intracavernosal pharmacotherapy-a multidisciplinary perspective, Los Angeles, March 22-23, 1996.